OMID Holdings

OMID

Drug Manufacturers - Specialty & Generic · Healthcare

Price

$0.03

+0.00 (+0.00%)

Market Cap

$2.3M

Winston Score

Winston is worried

Below-average fundamentals — multiple weak pillars.

Share count falling — buybacks

−44.9% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 174.8M (2021) → 96.3M (2025)

OMID Holdings is a small healthcare company focused on developing specialty pharmaceutical products. It works on drug treatments aimed at serious medical conditions, targeting patients and healthcare providers as its end customers. The company operates in the specialty and generic drug manufacturing industry, where it is in early stages compared to larger, established pharmaceutical firms.

OMID Holdings generates little to no revenue at this stage, as it has not yet brought significant commercial products to market. It operates primarily in the United States and has a very small market presence, reflected in its near-zero market capitalization and deeply negative margins. The central risk facing the company is its ability to fund ongoing operations and advance its drug pipeline through clinical development and regulatory approval, without which it cannot reach profitability.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+3.4% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+113.8% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

100.0%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~4 years

$41,405 cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

$41,405 cash & investments at current burn rate

Growth context

OMID Holdings is growing revenue at 3% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

42.5%

Healthy — 42.5% gross margin

Operating Margin

-47.7%

Losing money on operations — -47.7%

ROCE

-11.0%

Weak — -11.0% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

+59.2%

Fast-growing sales (59.2% YoY)

EPS YoY

N/A

Data not available

EPS Consistency

6/8 quarters

Earnings grew in most of the last 8 quarters

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

Data not available

FCF Margin

-33.0%

Burning cash (-33.0%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

4.05

Heavy debt load (4.05)

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial